However, a nonsignificant trend toward a lower CTLA4-positive cell count was observed among carriers of the rs231775 polymorphism vs noncarriers: 77.9 cells/mm 2 (95% CI: −51.5 to 207.5) vs 343.3 cells/mm 2 (95% CI: 126.2–560.4).
← all excerpts
Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis.
2
—
—
The sentences
However, carriers of the rs231775 variant showed a trend toward lower CTLA4 expression.